New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Prelude Therapeutics Incorporated (PRLD)
- Autolus Therapeutics PLC Sponsored ADR AUTL 0.91 −7.14%
- Prelude Therapeutics Incorporated PRLD 3.23 −0.92%
Autolus Therapeutics PLC Sponsored ADR and Prelude Therapeutics Incorporated are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Prelude Therapeutics Incorporated are of similar size ($260.9M and $260.5M). Autolus Therapeutics PLC Sponsored ADR has the higher net margin (−186.4% vs −247.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Prelude Therapeutics Incorporated leads on 11 and Autolus Therapeutics PLC Sponsored ADR on 4.
Valuation
Profitability
| Metric | AUTL | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | 35.76% | 100.00% | 70.18% |
| Operating margin | (159.61%) | (283.92%) | 0.00% |
| Net margin | (186.37%) | (247.12%) | 0.00% |
| Free cash flow margin | (131.12%) | (129.68%) | 0.00% |
| Return on equity | (174.92%) | (58.36%) | (51.58%) |
| Return on assets | (43.23%) | (39.45%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack